We pride ourselves on having an impressive product line, dedicated workforce and a strong distribution network. We are committed to providing quality-conscious healthcare products at affordable prices. During our short tenure, we are able to establish a cordial relationship with the reputed vendors. Owing to his efforts, we are able to extend our product range suiting customer’s demands.
Mission
Our vision is to become a leading pharmaceutical company which providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs.
Vision
To be a pharmaceutical company, Most Admired for its affordability, Superior Quality and Accessibility of Products. Affordability: Cost Effective innovative solutions for healthcare.
Quality
We value quality of our products from the core of our heart. Our products are manufactured at WHO FDA certifies & ISO certified plants, under the most stringent control to conform the international standard.
- Choose a bright future with us..
We’ll put you on the path to a healthier lifestyle.
A Healthy Family Means A Lot.
MEDOVITA Family
Quality Products At Affordable Prices
Product Range
Previous
Next
News
From latest articles
WHO: Next generation antibiotics needed
The pace of development of new antibacterial drugs has not kept up with the growing resistance to them. Antibiotics and other antimicrobials play a critical role in reducing morbidity and mortality in both humans and animals. However, as bacteria, viruses, fungi and parasites gradually mutate, new strains of micro-organisms develop that become resistant to these…
GOVERNMENT INITIATIVES
Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: As per the Union Budget 2022-23: Rs. 3,201 crore (US$ 419.2 million) has been set aside for research and Rs. 83,000 crore (US$ 10.86 billion) has been allocated for the Ministry of Health and Family Welfare. Rs.…
Indian Pharmaceutical Market
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market stood at US$ 42 billion in 2021 and is likely to reach US$ 65 billion by 2024 and further expand to reach US$ 120-130 billion by 2030. India’s biotechnology industry comprises biopharmaceuticals,…